[Selective serotonin reuptake inhibitors--current knowledge].
This article is a review of the current state of knowledge about possibilities of clinical use of selective serotonin reuptake inhibitors in different areas of psychopharmacotherapy. The authors presented information about pharmacodynamic and pharmacokinetic differences between SSRI's, and described emerging clinical consequences. The paper contains data about the most common and typical side effects and possible drug interactions. The reports and information about new therapeutic proposals concerning SSRI's are also discussed.
Dudek
Dominika
D
Zieba
Andrzej
A
Siwek
Marcin
M
Wróbel
Andrzej
A
D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D015283:Citalopram / Q000494:pharmacology / Q000627:therapeutic use; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use; D016666:Fluvoxamine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D017374:Paroxetine / Q000494:pharmacology / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D020280:Sertraline / Q000494:pharmacology / Q000627:therapeutic use
D000928:Antidepressive Agents; D015283:Citalopram; D005473:Fluoxetine; D016666:Fluvoxamine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline